Wednesday, June 18, 2025
22.9 C
Bengaluru

Opportunities for Indian Pharma

[wpfilebase tag=file id=75 tpl=download-button /]

Inside this Issue

1. Medical Rep to Country Head by Bhaskar Chakravorti
Bhaskar Chakravorti – Vice President, Micro Labs, talks about the growth of his career and his love for the country he presently calls ‘home’.

2. “Organizational Alignment Begins with a Common Vocabulary” by Hanno Wolfram
Our Editor Anup Soans sits down for a tête-à-tête with Hanno Wolfram – Owner, Innov8 and Member, MedicinMan Editorial Board.

3. Motivation: The No. 1 Challenge for Frontline Managers by K. Hariram
Motivation is created in teams only when ‘people’ and ‘purpose’ are prioritised.

4. A Pharma Technology Company Deeply Rooted in Experience by Krishna Singh
Krishna Singh spent 15 years in the Pharma Industry, beginning as a Medical Rep, before starting GlobalSpace technologies – a real Pharma field force multiplier.

5. Is Pharma Brand Management Promoting Mediocrity? by Shreenivas S
Simply hiring people because they have MBAs, without ascertaining their domain expertise or competency for the job, is a sure recipe for disaster. .

6. To Survive in the Jungle of Pharma Sales, Think like a Lion? by Chandan Kumar
Simple pointers to survive and thrive in the jungle of pharma sales.

7. Indian Pharma’s Many Challenges by Salil Kallianpur
The Indian Pharma Industry faces a multitude of challenges (and opportunities), some of which are unique to different sets of players, such as domestic Co’s and MNCs.

Hot this week

Careers in Medical Device Companies

Key Insights Thermo Fisher Scientific leads the industry with $42.88 billion...

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Topics

Careers in Medical Device Companies

Key Insights Thermo Fisher Scientific leads the industry with $42.88 billion...

Biologics Patent Cliff (2025–2029): A Golden Opportunity for Indian Pharma

https://www.pharmamanufacturing.com/articles/2011/095 A quiet but seismic shift is underway in global...

Zaynich and the $9 Billion Moment: A New Dawn for Indian Pharma?

A quiet but revolutionary milestone may be unfolding in...

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Semaglutide – More Than Just a Patent Battle

The Delhi High Court has restrained Dr. Reddy’s and...

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...
spot_img

Related Articles

spot_imgspot_img